Skip to main content
Erschienen in: Ophthalmology and Therapy 6/2023

Open Access 04.10.2023 | ORIGINAL RESEARCH

Optic Nerve Head Changes Measured by Swept Source Optical Coherence Tomography and Angiography in Patients with Intracranial Hypertension

verfasst von: Hang Wang, Le Cao, William Robert Kwapong, Guina Liu, Ruilin Wang, Junfeng Liu, Bo Wu

Erschienen in: Ophthalmology and Therapy | Ausgabe 6/2023

Abstract

Introduction

This study explored the structural and microvascular changes in the optic nerve head (ONH) of patients with intracranial hypertension (IH) by using swept-source optical coherence tomography (SS-OCT)/OCT angiography (OCTA) and evaluated their association with clinical features.

Methods

The optic disc morphology, peripapillary retinal nerve fiber layer (pRNFL), ganglion cell–inner plexiform layer (GCIPL), and microvascular densities of the nerve fiber layer plexus (NFLP), superficial vascular plexus (SVP), intermediate capillary plexus (ICP), and deep capillary plexus (DCP) were measured by the SS-OCT/OCTA tool. Frisen score, visual acuity, and intracranial pressure were assessed and recorded in patients with IH.

Results

Sixty-one patients with IH and 65 controls were included in this study. Patients with IH showed thicker pRNFL and GCIPL thickness with larger ONH rim area when compared to controls (P < 0.001). Microvascular densities were increased in NFLP while densities were reduced in SVP, ICP, and DCP when compared to controls (P < 0.001). Structural thickness and microvascular densities were significantly correlated with Frisen scores (P < 0.05) and intracranial pressure (P < 0.05) in patients with IH.

Conclusion

Structural and microvasculature variations of the ONH were found in patients with IH compared to controls. Importantly, we showed that structural and microvascular changes in the ONH were correlated with their Frisen score and intracranial pressure in patients with IH.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s40123-023-00822-w.
Hang Wang and Le Cao contributed equally to this project.
Key Summary Points
Why carry out this study?
Optic never head (ONH) is the main ocular site for intracranial hypertension; however, very little is known about microvessels in the ONH and their clinical manifestations.
Could the microvessels in the ONH reflect the clinical manifestations such as intracranial pressure and severity of papilledema?
What was learned from the study?
When compared to controls, patients with intracranial hypertension (IH) had structural and microvascular vascular abnormalities; these changes in IH correlated with their intracranial pressure and the severity of papilledema.
Imaging the optic nerve may be a potential tool for monitoring the structural and microvascular changes in patients with IH.

Introduction

Intracranial hypertension (IH) is a clinical disorder characterized by signs and symptoms of increased intracranial pressure. Clinical features including papilledema and visual loss and/or impairment strongly indicate that increased intracranial pressure affects the optic nerve head (ONH), an observation that has been supported by numerous studies [1, 2]. The long-term consequence of papilledema can lead to optic nerve atrophy [3, 4], ultimately resulting in poor quality of life [5].
A sensitive and reliable method for monitoring papilledema development as a result of increased intracranial pressure is lacking, even though the severity of papilledema and vision loss constitutes a foundation for therapeutic interventions. It has been emphasized that more sensitive methods are needed for monitoring the ONH changes in IH and their response to treatment, as well as their long-term visual outcome [6].
Optical coherence tomography (OCT) is suggested as a reliable technique for in vivo visualization of the macula and ONH. Longer wavelengths and faster imaging speed enable swept-source OCT (SS-OCT), which can simultaneously image the ONH and microvasculature with OCT angiography (OCTA), to give retinal imaging with an increasing depth of detail.
There is little information available about ONH changes in IH utilizing SS-OCT. Using the spectral domain OCT (SD-OCT), previous reports [79] evaluated the morphological changes around the ONH in patients with IH compared to controls. With the longer wavelength, SS-OCT/OCTA would provide a more accurate tissue profile and information about the microvasculature around the ONH in patients with IH. The current study aimed to assess the structural and microvascular changes in the ONH of patients with IH and evaluate their association with clinical features using the SS-OCT/OCTA.

Methods

Study Population

Patients with IH were enrolled from April 2021 to March 2023 in the Neurology Department of West China Hospital. IH diagnoses were made following international diagnostic standards [10] which revealed an elevated intracranial pressure greater than 250 mmH2O confirmed by lumbar puncture. The exclusion criteria were (1) the presence of other cerebral vascular diseases (e.g., arteriovenous malformation, aneurysm, and major artery stenosis or occlusion); (2) the presence of intracranial infections, including meningitis caused by bacteria, fungus, and virus; (3) presence of other neurological diseases (e.g., brain tumor, hydrocephalus, degeneration diseases); (4) uncontrolled hypertension and diabetes mellitus which have well-established pathogenesis that can affect the retinal structural integrity; (5) medical ailment requiring concomitant corticosteroids or immunosuppressant therapy. Controls were individuals who attended our hospital for an annual checkup and had no history of any neurological or ophthalmological diseases.
The Ethics Committee of West China Hospital, Sichuan University, China (No. 2020 [922]) approved the study and followed the tenets of the Declaration of Helsinki. Each participant provided written informed consent before enrolling in our study.

Intracranial Pressure, Frisen Score, and Visual Acuity Assessment

An open pressure reading was taken at the L3–4 intervertebral space, left lateral position, after the fluctuating liquid levels in the manometer were stabilized.
A Frisen score was used to clinically grade each eye from 0 (normal) to 5 (severe papilledema) using the modified Frisen scale [11]. A single rater blinded to the clinical information and OCT/OCTA data assessed the Frisen score by fundus imaging of each participant. A second rater evaluated a random sample of 30 patients (60 eyes) to assess inter-rater agreement (kappa 0.91, P < 0.001).
The visual acuity (VA) of each eye of our participants was examined using the Snellen chart and later converted to a logarithm of the minimum angle of resolution (logMAR).
Fundus photography was performed on all participants to evaluate the ONH and fundus of all participants. Participants with abnormalities such as hemorrhages, microaneurysms, and hard exudates were excluded from our study. Two ophthalmologists (Guina Liu and Ruilin Wang) examined all images. Patients with IH also underwent intraocular pressure (IOP) examination. Patients with IOP > 21 mmHg or a previous diagnosis of glaucoma were excluded from our study.

Optic Nerve Head Imaging

The SS-OCT/OCTA tool (VG200S; SVision Imaging, Henan, China; version 2.1.016) contained a swept source laser with a central wavelength of 1050 nm and a scan rate of 200,000 A-scans per second. The tool is integrated with an eye tracker to compensate for the artifacts caused by blinking. The SS-OCT ONH scan covers an area of 6 × 6 mm focused on the optic disc. Ganglion cell and inner plexiform layer (GCIPL) was automatically segmented. In the ONH Angio mode, GCIPL, peripapillary retinal nerve fiber layer (pRNFL), and ONH rim data were obtained from the OCT tool. The GCIPL was the mean thickness of these layers in a 4.0-mm circle around the ONH. ONH rim was automatically evaluated by the OCT tool. ONH rim area was defined as the disc area minus the cup area. Automated placement of a circle with a diameter of 3.4 mm, centered on the disc, was used to measure the mean pRNFL as shown in Fig. 1. Manual adjustment of circle placement was performed if necessary.
ONH angiography imaging was conducted using 6 × 6 mm scans. En face angiograms of the nerve fiber layer plexus (NFLP), superficial vascular plexus (SVP), intermediate capillary plexus (ICP), and deep capillary plexus (DCP) were generated by the OCTA tool. NFLP was defined as the microvasculature found 5 µm below the inner limiting membrane (ILM) border to the nerve fiber layer (NFL) and ganglion cell layer (GCL) border. The SVP was defined as the microvasculature between the NFL/GCL border and the junction between the inner plexiform layer (IPL) and inner nuclear layer (INL); ICP was defined as the microvasculature between the IPL/INL border and the junction between INL and outer plexiform layer (OPL); DCP was defined as the microvasculature between the INL/OPL border and 25 µm below it as shown in Fig. 1. Average microvascular density was used to evaluate the ONH microvasculature which was generated by the OCTA tool. OCT/OCTA images with ophthalmic disorders such as age-macular degeneration, severe cataracts, optic neuritis, diabetic retinopathy, and optic neuritis were excluded. Individuals with low signal quality (SQ) on OCT/OCTA images (SQ < 6) were excluded from the study. The OSCAR-IB quality criteria [12] and APOSTEL recommendation [13] were followed in OCT/OCTA data.

Statistical Analysis

Continuous variables with a normal distribution were expressed as mean ± standard deviation (SD) or expressed as the median and interquartile range (IQR) for skewed distributions; categorical variables were presented as frequencies and percentages. A comparison of demographic and clinical characteristics between patients with IH and controls was performed using the Fisher exact test for categorical variables and a t test for continuous variables. The differences in OCT/OCTA parameters between patients with IH and controls were performed by generalized estimating equations (GEE). GEE were also used to evaluate the correlations between OCT/OCTA data and clinical information. Covariates for GEE were set as age and gender while the correlation matrix in GEE was set as exchangeable. The added variable plot was used to show the partial correlation between clinical manifestations and OCT/OCTA parameters. The X-axis and Y-axis of added variable plots were the residuals of the dependent variable and the independent variable when both of these variables were regressed on the covariates (risk factors). P values less than 0.05 were considered statistically significant. All statistical analysis and plotting were conducted using R 4.2.3.

Results

A total of 121 eyes from 61 patients with IH (28 male, 33 female; mean age 34.51 years) and 130 eyes from 65 controls (23 male, 42 female; mean age 40.52 years) were included in our final analysis. Out of 121 eyes from patients with IH, 69 eyes had no or mild papilledema while 52 eyes had moderate or severe papilledema. The median Frisen score of patients with IH was 2 (IQR 1–4). The mean intracranial pressure was 291 mmH2O in patients with IH. Table 1 shows the demographics and clinical information of our study participants.
Table 1
Characteristics of participants
 
IH
Controls
P value
Participants, n
61
65
Eyes, n
121
130
Age, years
34.51 ± 11.85
40.52 ± 12.38
0.007*
Gender, male, n (%)
28 (45.9)
23 (35.38)
0.308
Frisen score
2 (1–4)
0
< 0.001*
VA (logMAR)
0.65 ± 0.34
0.98 ± 0.14
< 0.001*
Intracranial pressure (mmH2O)
291.15 ± 67.86
Hypertension, n (%)
9 (14.75)
7 (10.94)
0.711
Dyslipidemia, n (%)
9 (14.75)
4 (6.25)
0.206
Diabetes, n (%)
4 (6.56)
2 (3.08)
0.429
Smokers, n (%)
16 (26.23)
6 (9.23)
0.025*
Papilledema
 Mild (Frisen score 1), n
37
 Moderate (Frisen 2–3), n
30
 Severe (Frisen 4–5), n
44
Patients with unilateral papilledema
2
Patients with bilateral papilledema
55
VA visual acuity, logMAR logarithm of the minimum angle of resolution
*P < 0.05

Comparison of OCT/OCTA Parameters Between Patients with IH and Controls

Figure 2 shows the differences in OCT/OCTA parameters between IH and controls. pRNFL and GCIPL structures of patients with IH were thicker when compared with controls (P < 0.001). Microvascular densities in SVP, ICP, and DCP of patients with IH were reduced (P < 0.001) while NFLP was increased significantly (P < 0.001) when compared with controls. Compared with controls, the ONH rim area was increased significantly (P < 0.001).
We stratified patients with IH into two groups (no/mild papilledema, Frisen score 0–2; moderate/severe papilledema, Frisen score 3–5) according to their Frisen scores. The ONH structure of eyes in the no/mild papilledema group was thinner than that in the moderate/severe group (P < 0.001, Supplementary Fig. 1). Microvascular densities were decreased in SVP, ICP, and DCP while NFLP was increased in the moderate/severe papilledema group (P < 0.001, Supplementary Fig. 1).

Association Between OCT/OCTA Parameters and Clinical Data

Structural thicknesses, ONH rim area, and microvascular densities showed a significant correlation with Frisen scores and intracranial pressure (P < 0.05, Figs. 3 and 4). No association was found between OCT/OCTA measures of ONH in patients with IH and visual acuity (P > 0.05, data not shown).

Discussion

The present study assessed the ONH structural and microvascular changes in patients with IH compared to controls. While comparable analyses of the structural alterations in the optic disc have been carried out, to the best of our knowledge, we provided the first study to focus on the ONH microvascular changes in patients with IH compared to controls. We showed that patients with IH had thicker ONH structures and larger ONH rim areas compared to controls. Besides, patients with IH had increased NFLP density and reduced SVP, ICP, and DCP densities in the ONH when compared to controls. Importantly we showed that thicker ONH structures and decreased microvascular densities in the ONH were associated with their intracranial pressure and Frisen score, highlighting the potential clinical relevance of these parameters.
Previous reports [7, 14, 15] using SD-OCT have shown the morphometric changes in and around the ONH and therefore our approach is not entirely new. Previous reports [7, 16] showed that patients with IH had larger ONH volumes compared to controls. SD-OCT uses a low-coherence light source and produces an interference spectrum by spectral splitting, while SS-OCT uses a broadband swept source whose wavelength varies over time [17]. With a longer wavelength and higher speed, the SS-OCT is a more recent advancement of the SD-OCT that allows for better and more detailed visualization of deeper microvasculature [18, 19]. Therefore, at deeper scanning depths, the SS-OCT is more sensitive and has a lower signal-to-noise ratio compared to the SD-OCT. Using SS-OCT we showed that patients with IH had thicker pRNFL and GCIPL thicknesses when compared to controls. We also showed that ONH rim area was larger in patients with IH compared to controls. We suggest that the thickening of the ONH structural parameters may be due to the increased intracranial pressure which may be transmitted to the expandable leptomeningeal sheath surrounding the optic nerve via passage of the excess cerebrospinal fluid into the tiny rim of the subarachnoid space between the sheath and the nerve as previously reported [20]. Taken together, since these structural parameters of the ONH were reflections of their neuroaxonal integrity, thicker pRNFL and GCIPL thicknesses, and ONH rim area may reflect swelling of the neuroaxons due to increased intracranial pressure.
By compressing the microvasculature due to swollen axons and extracellular fluid buildup as a result of edema, IH is thought to increase the risk of ischemia and decrease blood flow. This increases vascular resistance, venous congestion, and stasis, which in turn increases venous pressure and decreases perfusion pressure [21, 22]. This makes the ONH susceptible to ischemia in IH. Using SS-OCTA we showed that patients with IH had increased NFLP microvascular density and reduced SVP, ICP, and DCP densities when compared to controls. The NFLP contains capillaries, arterioles, and venules that reside in the NFL which extends beyond the peripapillary region [23]; it perfuses the NFL and forms a microvascular network in the peripapillary region making it sensitive to ischemic changes. The increased NFLP density seen in IH may be due to compression of capillaries, extracellular fluid accumulation in edema, and venous congestion. The SVP, ICP, and DCP are found beneath the NFLP; thus, reduced microvascular densities in these plexuses may be due to reduced blood flow from the NFLP to these microvascular plexuses.
We further divided the IH group according to their Frisen scores using the modified Frisen scale. We found that patients with moderate/severe papilledema IH had increased NLFP density, reduced SVP, ICP, and DCP density, and thicker ONH structural thicknesses compared to patients with no/mild papilledema IH. Clinical hallmarks of elevated intracranial pressure that affect the ONH include papilledema, the absence of spontaneous retinal venous pulsations, and peripapillary retinal vein engorgement [22]. We suggest that the severity of papilledema affects the ONH microvasculature and structure.
The main clinical method for evaluating papilledema in patients with IH is the Frisen score. It is proposed that in patients with newly diagnosed IH, assessments of papilledema utilizing more modern technologies, such as fundus photography and OCT, are associated with Frisen scores [11, 24]. Even though OCT/OCTA was used in clinical practice to evaluate structural and microvascular changes in ONH, we showed that Frisen score correlated with structural and microvascular changes in and around the ONH in patients with IH. Our findings suggest that imaging with the OCT/OCTA tool can be useful in the assessment of papilledema by confirming or complementing a clinician’s examination in patients with IH.
Previous reports [7, 25] showed a weak correlation between global ONH volume and intracranial pressure in patients with IH. We showed a strong correlation between intracranial pressure and structural and microvascular changes of ONH in patients with IH. Thus, it is plausible to suggest that OCT/OCTA measures may be sensitive indicators of increased intracranial pressure in patients with IH.
Structure–function correlations are important, in that moving from visual acuity examinations to objective clinical tools, such as OCT/OCTA, would be advantageous for patients and clinicians. Macular structural measurements are accurate and reliable indicators of visual acuity changes [26, 27]. Besides, previous reports [2831] showed that structural macular thickness changes in patients with IH correlated with reduced visual acuity. However, our current study did not find an association between OCT/OCTA measures of ONH in patients with IH and their visual acuity. This may suggest that the structural and microvascular changes in and around the ONH of patients with IH may not be linked with visual acuity.
We would like to acknowledge some limitations. Firstly, assessment of the intracranial pressure was not done in our controls and thus changes seen in our patients with IH may not be predominantly from increased intracranial pressure as speculated. Future studies may be needed to evaluate how changes in the intracranial pressure may affect OCT/OCTA metrics. Additionally, the relatively small sample size and the cross-sectional design of our study limit the interpretation of the cause and effect of the results shown in our report. Longitudinal studies with larger sample sizes are needed to validate our findings. Moreover, participants with ocular comorbidities and inability to undergo OCT/OCTA imaging were excluded which might introduce selection bias. The strengths of this study include an assessment of the structural and microvascular parameters in ONH of patients with IH and a cohort spanning varying degrees of papilledema.

Conclusion

The ONH structure and microvasculature were significantly different in patients with IH compared to controls. Importantly, we showed that structural and microvascular changes in the ONH were correlated with their Frisen score and intracranial pressure in patients with IH. Patients with IH may benefit from monitoring ONH structural and microvascular changes with the OCT/OCTA tool.

Declarations

Conflict of interest

All named authors declare that they have no conflicts of interest.

Ethical Approval

The Ethics Committee of West China Hospital, Sichuan University, China (No. 2020 [922]) approved the study and followed the tenets of the Declaration of Helsinki. Each participant provided written informed consent before enrolling in our study.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by-nc/​4.​0/​.
Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Nusbaum DM, Wu SM, Frankfort BJ. Elevated intracranial pressure causes optic nerve and retinal ganglion cell degeneration in mice. Exp Eye Res. 2015;136:38–44.CrossRefPubMedPubMedCentral Nusbaum DM, Wu SM, Frankfort BJ. Elevated intracranial pressure causes optic nerve and retinal ganglion cell degeneration in mice. Exp Eye Res. 2015;136:38–44.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Zhu Z, Waxman S, Wang B, et al. Interplay between intraocular and intracranial pressure effects on the optic nerve head in vivo. Exp Eye Res. 2021;213:108809.CrossRefPubMedPubMedCentral Zhu Z, Waxman S, Wang B, et al. Interplay between intraocular and intracranial pressure effects on the optic nerve head in vivo. Exp Eye Res. 2021;213:108809.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Reier L, Fowler JB, Arshad M, et al. Optic disc edema and elevated intracranial pressure (ICP): a comprehensive review of papilledema. Cureus. 2022;14(5):e24915.PubMedPubMedCentral Reier L, Fowler JB, Arshad M, et al. Optic disc edema and elevated intracranial pressure (ICP): a comprehensive review of papilledema. Cureus. 2022;14(5):e24915.PubMedPubMedCentral
5.
Zurück zum Zitat Virdee J, Larcombe S, Vijay V, Sinclair AJ, Dayan M, Mollan SP. Reviewing the recent developments in idiopathic intracranial hypertension. Ophthalmol Ther. 2020;9(4):767–81.CrossRefPubMedPubMedCentral Virdee J, Larcombe S, Vijay V, Sinclair AJ, Dayan M, Mollan SP. Reviewing the recent developments in idiopathic intracranial hypertension. Ophthalmol Ther. 2020;9(4):767–81.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Sinclair AJ, Burdon MA, Nightingale PG, et al. Rating papilloedema: an evaluation of the Frisen classification in idiopathic intracranial hypertension. J Neurol. 2012;259(7):1406–12.CrossRefPubMed Sinclair AJ, Burdon MA, Nightingale PG, et al. Rating papilloedema: an evaluation of the Frisen classification in idiopathic intracranial hypertension. J Neurol. 2012;259(7):1406–12.CrossRefPubMed
7.
Zurück zum Zitat Dreesbach M, Joachimsen L, Kuchlin S, et al. Optic nerve head volumetry by optical coherence tomography in papilledema related to idiopathic intracranial hypertension. Transl Vis Sci Technol. 2020;9(3):24.CrossRefPubMedPubMedCentral Dreesbach M, Joachimsen L, Kuchlin S, et al. Optic nerve head volumetry by optical coherence tomography in papilledema related to idiopathic intracranial hypertension. Transl Vis Sci Technol. 2020;9(3):24.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Albrecht P, Blasberg C, Ringelstein M, et al. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension. J Neurol. 2017;264(7):1370–80.CrossRefPubMed Albrecht P, Blasberg C, Ringelstein M, et al. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension. J Neurol. 2017;264(7):1370–80.CrossRefPubMed
9.
Zurück zum Zitat Vijay V, Mollan SP, Mitchell JL, et al. Using optical coherence tomography as a surrogate of measurements of intracranial pressure in idiopathic intracranial hypertension. JAMA Ophthalmol. 2020;138(12):1264–71.CrossRefPubMed Vijay V, Mollan SP, Mitchell JL, et al. Using optical coherence tomography as a surrogate of measurements of intracranial pressure in idiopathic intracranial hypertension. JAMA Ophthalmol. 2020;138(12):1264–71.CrossRefPubMed
10.
Zurück zum Zitat Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159–65.CrossRefPubMed Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159–65.CrossRefPubMed
11.
Zurück zum Zitat Fischer WS, Wall M, McDermott MP, Kupersmith MJ, Feldon SE, NORDIC Idiopathic Intracranial Hypertension Study Group. Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): methods and baseline results. Invest Ophthalmol Vis Sci. 2015;56(5):3292–303. Fischer WS, Wall M, McDermott MP, Kupersmith MJ, Feldon SE, NORDIC Idiopathic Intracranial Hypertension Study Group. Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): methods and baseline results. Invest Ophthalmol Vis Sci. 2015;56(5):3292–303.
12.
13.
Zurück zum Zitat Aytulun A, Cruz-Herranz A, Aktas O, et al. APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies. Neurology. 2021;97(2):68–79. Aytulun A, Cruz-Herranz A, Aktas O, et al. APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies. Neurology. 2021;97(2):68–79.
14.
Zurück zum Zitat Huang-Link YM, Al-Hawasi A, Oberwahrenbrock T, Jin YP. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension. Clin Neurol Neurosurg. 2015;130:122–7.CrossRefPubMed Huang-Link YM, Al-Hawasi A, Oberwahrenbrock T, Jin YP. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension. Clin Neurol Neurosurg. 2015;130:122–7.CrossRefPubMed
15.
Zurück zum Zitat Hoffmann J, Kreutz KM, Csapo-Schmidt C, et al. The effect of CSF drain on the optic nerve in idiopathic intracranial hypertension. J Headache Pain. 2019;20(1):59.CrossRefPubMedPubMedCentral Hoffmann J, Kreutz KM, Csapo-Schmidt C, et al. The effect of CSF drain on the optic nerve in idiopathic intracranial hypertension. J Headache Pain. 2019;20(1):59.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Miller AR, Roisman L, Zhang Q, et al. Comparison between spectral-domain and swept-source optical coherence tomography angiographic imaging of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2017;58(3):1499–505. Miller AR, Roisman L, Zhang Q, et al. Comparison between spectral-domain and swept-source optical coherence tomography angiographic imaging of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2017;58(3):1499–505.
18.
Zurück zum Zitat Haas AM, Ahmed D, Stattin M, Graf A, Krepler K, Ansari-Shahrezaei S. Comparison of macular neovascularization lesion size by the use of spectral-domain optical coherence tomography angiography and swept-source optical coherence tomography angiography versus indocyanine green angiography. Acta Ophthalmol. 2021;99(2):e260–6.CrossRefPubMed Haas AM, Ahmed D, Stattin M, Graf A, Krepler K, Ansari-Shahrezaei S. Comparison of macular neovascularization lesion size by the use of spectral-domain optical coherence tomography angiography and swept-source optical coherence tomography angiography versus indocyanine green angiography. Acta Ophthalmol. 2021;99(2):e260–6.CrossRefPubMed
19.
Zurück zum Zitat Ting DS, Cheung GC, Lim LS, Yeo IY. Comparison of swept source optical coherence tomography and spectral domain optical coherence tomography in polypoidal choroidal vasculopathy. Clin Exp Ophthalmol. 2015;43(9):815–9.CrossRefPubMed Ting DS, Cheung GC, Lim LS, Yeo IY. Comparison of swept source optical coherence tomography and spectral domain optical coherence tomography in polypoidal choroidal vasculopathy. Clin Exp Ophthalmol. 2015;43(9):815–9.CrossRefPubMed
20.
Zurück zum Zitat Toscano S, Lo Fermo S, Reggio E, Chisari CG, Patti F, Zappia M. An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management. J Neurol. 2021;268(9):3249–68.CrossRefPubMed Toscano S, Lo Fermo S, Reggio E, Chisari CG, Patti F, Zappia M. An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management. J Neurol. 2021;268(9):3249–68.CrossRefPubMed
21.
Zurück zum Zitat Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res. 2001;20(5):595–624.CrossRefPubMed Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res. 2001;20(5):595–624.CrossRefPubMed
23.
Zurück zum Zitat Hormel TT, Jia Y, Jian Y, et al. Plexus-specific retinal vascular anatomy and pathologies as seen by projection-resolved optical coherence tomographic angiography. Prog Retin Eye Res. 2021;80:100878.CrossRefPubMed Hormel TT, Jia Y, Jian Y, et al. Plexus-specific retinal vascular anatomy and pathologies as seen by projection-resolved optical coherence tomographic angiography. Prog Retin Eye Res. 2021;80:100878.CrossRefPubMed
24.
Zurück zum Zitat OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, Auinger P, Durbin M, et al. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. Invest Ophthalmol Vis Sci. 2014;55(12):8173–9. OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, Auinger P, Durbin M, et al. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. Invest Ophthalmol Vis Sci. 2014;55(12):8173–9.
25.
Zurück zum Zitat Kaufhold F, Kadas EM, Schmidt C, et al. Optic nerve head quantification in idiopathic intracranial hypertension by spectral domain OCT. PLoS ONE. 2012;7(5):e36965.CrossRefPubMedPubMedCentral Kaufhold F, Kadas EM, Schmidt C, et al. Optic nerve head quantification in idiopathic intracranial hypertension by spectral domain OCT. PLoS ONE. 2012;7(5):e36965.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Charbel Issa P, Troeger E, Finger R, Holz FG, Wilke R, Scholl HP. Structure-function correlation of the human central retina. PLoS ONE. 2010;5(9):e12864.CrossRefPubMedPubMedCentral Charbel Issa P, Troeger E, Finger R, Holz FG, Wilke R, Scholl HP. Structure-function correlation of the human central retina. PLoS ONE. 2010;5(9):e12864.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Poh S, Tham YC, Chee ML, et al. Association between macular thickness profiles and visual function in healthy eyes: the Singapore Epidemiology of Eye Diseases (SEED) study. Sci Rep. 2020;10(1):6142.CrossRefPubMedPubMedCentral Poh S, Tham YC, Chee ML, et al. Association between macular thickness profiles and visual function in healthy eyes: the Singapore Epidemiology of Eye Diseases (SEED) study. Sci Rep. 2020;10(1):6142.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Monteiro ML, Afonso CL. Macular thickness measurements with frequency domain-OCT for quantification of axonal loss in chronic papilledema from pseudotumor cerebri syndrome. Eye (Lond). 2014;28(4):390–8.CrossRefPubMed Monteiro ML, Afonso CL. Macular thickness measurements with frequency domain-OCT for quantification of axonal loss in chronic papilledema from pseudotumor cerebri syndrome. Eye (Lond). 2014;28(4):390–8.CrossRefPubMed
29.
Zurück zum Zitat Nogueira PF, Caiado GC, Gracitelli CPB, et al. Association between optical coherence tomography measurements and clinical parameters in idiopathic intracranial hypertension. J Ophthalmol. 2021;2021:1401609.CrossRefPubMedPubMedCentral Nogueira PF, Caiado GC, Gracitelli CPB, et al. Association between optical coherence tomography measurements and clinical parameters in idiopathic intracranial hypertension. J Ophthalmol. 2021;2021:1401609.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Banerjee M, Phuljhele S, Saluja G, et al. Optical coherence tomography features and correlation of functional and structural parameters in patients of idiopathic intracranial hypertension. Indian J Ophthalmol. 2022;70(4):1343–9.CrossRefPubMedPubMedCentral Banerjee M, Phuljhele S, Saluja G, et al. Optical coherence tomography features and correlation of functional and structural parameters in patients of idiopathic intracranial hypertension. Indian J Ophthalmol. 2022;70(4):1343–9.CrossRefPubMedPubMedCentral
Metadaten
Titel
Optic Nerve Head Changes Measured by Swept Source Optical Coherence Tomography and Angiography in Patients with Intracranial Hypertension
verfasst von
Hang Wang
Le Cao
William Robert Kwapong
Guina Liu
Ruilin Wang
Junfeng Liu
Bo Wu
Publikationsdatum
04.10.2023
Verlag
Springer Healthcare
Erschienen in
Ophthalmology and Therapy / Ausgabe 6/2023
Print ISSN: 2193-8245
Elektronische ISSN: 2193-6528
DOI
https://doi.org/10.1007/s40123-023-00822-w

Weitere Artikel der Ausgabe 6/2023

Ophthalmology and Therapy 6/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.